A holistic view of advanced heart failure
F Triposkiadis, G Giamouzis, T Kitai, J Skoularigis… - Life, 2022 - mdpi.com
Advanced heart failure (HF) may occur at any level of left ventricular (LV) ejection fraction
(LVEF). The latter, which is widely utilized for the evaluation of LV systolic performance and …
(LVEF). The latter, which is widely utilized for the evaluation of LV systolic performance and …
Medical therapy of cardiogenic shock: Contemporary use of inotropes and vasopressors
M Riccardi, M Pagnesi, O Chioncel… - European Journal of …, 2024 - Wiley Online Library
Cardiogenic shock is a primary cardiac disorder that results in both clinical and biochemical
evidence of tissue hypoperfusion and can lead to multi‐organ failure and death depending …
evidence of tissue hypoperfusion and can lead to multi‐organ failure and death depending …
Right ventricular dysfunction in left ventricular assist device candidates: is it time to change our prospective?
C Sciaccaluga, MC Procopio, L Potena, M Masetti… - Heart Failure …, 2024 - Springer
The use of left ventricular assist devices (LVAD) has significantly increased in the last years,
trying to offer a therapeutic alternative to heart transplantation, in light also to the significant …
trying to offer a therapeutic alternative to heart transplantation, in light also to the significant …
Outpatient Continuous Intravenous Inotropy in the Modern Era
T Fishkin, Y Spira, A D'Ascanio, S Bahl… - Cardiology in …, 2024 - journals.lww.com
The use of continuous inotropy in patients with advanced heart failure (HF) has been
historically controversial due to the prevailing notion that it will increase mortality. In practice …
historically controversial due to the prevailing notion that it will increase mortality. In practice …
Successful conservative management of left ventricular assist device candidates
O Havakuk, A Hochstadt, S Sadon… - ESC Heart …, 2023 - Wiley Online Library
Abstract Aims Clinical trials comparing LVADs vs. conservative therapy were performed
before the availability of novel medications or used suboptimal medical therapy. This study …
before the availability of novel medications or used suboptimal medical therapy. This study …
Comparative effectiveness and safety of intermittent, repeated or continuous use of levosimendan, milrinone, or dobutamine in patients with advanced heart failure: a …
X Zhang, Z Wang, L Zhang, X Zhao… - Journal of Cardiovascular …, 2022 - journals.lww.com
To synthesize the available evidence regarding differences in the long-term safety and
efficacy of intermittent, repeated, or continuous palliative inotropic therapy among patients …
efficacy of intermittent, repeated, or continuous palliative inotropic therapy among patients …
Terapia inotrópica em pacientes com insuficiência cardíaca crônica avançada
VG Pansani, AVF Vieira, GA Viana… - Revista Eletrônica …, 2024 - acervomais.com.br
Objetivo: Analisar sobre a terapia inotrópica, as principais inseguranças e o cenário clínico
para implementação em pacientes com Insuficiência Cardíaca (IC) Avançada. Revisão …
para implementação em pacientes com Insuficiência Cardíaca (IC) Avançada. Revisão …